BSECentuple Global LtdMediumNeutral
Announced Mon, 7 Apr · 17:09 IST

Checkpoint Trends Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2025 ,inter alia, to consider and approve 1. Increase in the Authorized ....

Corporate Actions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Checkpoint Trends Ltd has called a board meeting on April 15, 2025 to consider four key items: (1) increasing the Authorized Share Capital of the company, (2) amending the Object Clause of its Memorandum of Association, (3) shifting the Registered Office, and (4) approving a Postal Ballot notice covering these matters along with regularization of director appointments and Whole-Time Director remuneration. All three substantive items (capital increase, object change, and office shift) require shareholder approval. The company, formerly known as Rubra Medicaments Limited, trades on BSE under scrip code 531099.

Likely market impact

An increase in Authorized Share Capital often signals upcoming fundraising or equity expansion, which could lead to dilution for existing shareholders, though no specific issuance size or pricing is disclosed yet. Shareholders should watch for the Postal Ballot notice for details on the capital change, business purpose behind the Object Clause amendment, and any new director appointments.